A Systematic Review of Neoadjuvant Therapy Compared to the “Resection First” Approach for Patients With Borderline Resectable Pancreatic Adenocarcinoma

Journal of Cancer Therapy
doi 10.4236/jct.2014.51012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

Increased Neutrophil-To-Lymphocyte Ratio After Neoadjuvant Therapy Is Associated With Worse Survival After Resection of Borderline Resectable Pancreatic Ductal Adenocarcinoma

Surgery
Surgery
2016English

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Clinical Medicine
2020English

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients With Resectable Pancreatic Ductal Adenocarcinoma

HPB Surgery
SurgeryHepatology
2013English

Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study

International Journal of Contemporary Medical Research [IJCMR]
2019English

Meta-Analysis Comparing Upfront Surgery With Neoadjuvant Treatment in Patients With Resectable or Borderline Resectable Pancreatic Cancer

British Journal of Surgery
Surgery
2018English

A Pilot Study- Neoadjuvant Chemotherapy With Gemcitabine and S1 in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Journal of Carcinogenesis & Mutagenesis
2013English

Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

Oncologist
Cancer ResearchMedicineOncology
2019English

Preoperative Nomogram to Predict Survival for Patients With Resectable and Borderline Resectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2017English

Neoadjuvant Imatinib for Borderline Resectable GIST

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy